Total Funding
57
64
Total FundingSeries A raised
Growth Score 57 in past quarter
-3 pts
Heat Score 64 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
25780
Peel Therapeutics is a biotech company that develops medicines for cancer and inflammatory diseases.
- Jim Levison: CFO
- Joshua Schiffman: Chief Executive Officer
About the Company
Peel Therapeutics is a clinical-stage biotech business that is creating drugs to improve the lives of patients. Peel (Hebrew for "elephant") began by focusing on cancer-fighting proteins in elephants, and we rapidly realized the power of leveraging evolution's answers to treat and prevent disease. In addition to producing elephant
p53 (EP53) nanoparticles for cancer treatment, our team is expanding new cancer and inflammation medicines derived from nature's superpowers.